MyETF.app
HomeUS Marketequity › CANC

CANC — Tema Oncology ETF

Tema Oncology ETF (ticker: CANC) is a equity ETF issued by Tema Global Ltd. tracking ACTIVE - No Index. It was launched on 2023-08-15.

Live Price$36.7875
Change2.16%
AUM$168.41M
Expense Ratio0.01%
Avg Volume19,081.947

Returns (Total Return)

PeriodReturn
1 Day-0.86%
1 Week-3.07%
1 Month-3.34%
3 Months-1.96%
6 Months2.87%
YTD4.02%
1 Year41.19%
3 Years
5 Years
10 Years
Since Inception

Top Holdings

#SecuritySymbolWeight
1 REVOLUTION MEDICINES INC RVMD 7.08%
2 REVOLUTION MEDICINES INC RVMD 7.08%
3 REVOLUTION MEDICINES INC RVMD 7.08%
4 REVOLUTION MEDICINES INC RVMD 7.08%
5 REVOLUTION MEDICINES, INC. RVMD 6.28%
6 REVOLUTION MEDICINES, INC. RVMD 6.28%
7 REVOLUTION MEDICINES, INC. RVMD 6.28%
8 REVOLUTION MEDICINES, INC. RVMD 6.28%
9 REVOLUTION MEDICINES, INC. RVMD 6.28%
10 REVOLUTION MEDICINES, INC. RVMD 6.28%

Fund Profile

IssuerTema Global Ltd.
BrandTema
Asset Classequity
StrategyActive
StructureETF
CategoryHealth & Biotech Equities
SegmentEquity: Global Pharma, Biotech & Life Sciences
RegionGlobal
Index TrackedACTIVE - No Index
Inception Date2023-08-15

Quick Facts

TickerCANC
Full NameTema Oncology ETF
IssuerTema Global Ltd.
Asset Classequity
Expense Ratio0.01%
AUM$168.41M
Inception2023-08-15
Index TrackedACTIVE - No Index

Frequently Asked Questions

What does CANC track?

CANC (Tema Oncology ETF) tracks ACTIVE - No Index, a equity benchmark.

What is the expense ratio of CANC?

CANC has an expense ratio of 0.01% per year.

What is the AUM of CANC?

CANC has approximately $168.41M in assets under management.

Does CANC pay a dividend?

CANC distributes income according to its prospectus. Check the dividend history tab for ex-dividend dates and yield.

Who issues CANC?

CANC is issued by Tema Global Ltd. under the Tema brand, launched on 2023-08-15.

Open the interactive CANC dashboard for charts, historical fund flows, holdings breakdown and seasonality patterns.